Minnesota Lawmakers Have Put Psychedelics-Related Rules Into A Big Health Bill That Will Be Voted On Soon On The Floor!

Minnesota Lawmakers Have Put Psychedelics-Related Rules Into A Big Health Bill That Will Be Voted On Soon On The Floor!

Large-scale omnibus health legislation that may soon be debated on the House floor has components from a bill that would establish a task committee to study the legalization of psychedelics and prepare Minnesota for it.

Last Monday, the House Health Finance and Policy Committee approved an author’s amendment to the larger bill that added a modified version of Rep. Andy Smith’s psychedelics provision. (D).

The measure states that, if adopted, the Psychedelic Medicine Task Force would be tasked with advising lawmakers on the legal, medical, and policy concerns related to the legalization of psychedelic medicine in the state.

Research on the therapeutic effectiveness of psychedelic drugs in the treatment of mental health conditions, such as depression, anxiety, post-traumatic stress disorder, and bipolar disorder, as well as any other mental health conditions and medical conditions for which a psychedelic drug may provide an effective treatment option, would need to be reviewed in the scientific literature.

ALSO READ: Feds Charge a Former Speaker of The Michigan House Of Representatives With Bribery In A Marijuana Licensing Case!

Minnesota Lawmakers Have Put Psychedelics-Related Rules Into A Big Health Bill That Will Be Voted On Soon On The Floor!

It would then create a plan that addressed state and local control of psychedelic medicine as well as the statutory modifications required for their legalization.

The Ways & Means Committee still needs to approve the omnibus, but that may come as soon as next week after the members return from their break. If it passed through that panel, the floor would be its next stop.

The psychedelics law as it was introduced in standalone form underwent two substantial alterations as a result of the author’s amendment that was adopted in committee, in addition to a few primarily technical amendments. First, only psilocybin, MDMA, and LSD would remain on the task force’s list of substances.

Previously, the task force would have been told to investigate ketamine, ibogaine, salvinorin A, DMT, 5-MeO-DMT, bufotenine, mescaline, and more.

The amendment was also passed by the panel last week without the task force appointment requirements’ earlier committee-approved revision. The sponsor amended the legislation so that both the majority and minority leaders of each house could nominate one member in an effort to increase the bill’s bipartisan appeal. But Omnibus has removed that modification.

ALSO READ: Where Presidential Candidate Marianne Williamson Stands On Marijuana?

Minnesota Lawmakers Have Put Psychedelics-Related Rules Into A Big Health Bill That Will Be Voted On Soon On The Floor!

Unfortunately, the majority of these pharmaceuticals kind of got tied up in the global drug trade in the 1980s, and as a result, there are many out-of-date rules that are impeding both research and the ability to use these drugs for therapy, Smith recently told KIMT-TV. The task force’s objective is to determine how we may properly and effectively repeal those restrictions.

He claimed that psychoactive substances have a tremendous potential to treat depression at a considerably lower cost.

The 23-member task force would have to be composed of representatives and experts, including the governor or a designee, the health commissioner, the state attorney general or a designee, two tribal representatives, individuals with knowledge of the treatment of substance abuse, public health policy experts, and more.

The task force is required to submit two reports outlining its findings regarding the legalization of psychedelic medicine in the state, including the comprehensive plan created under subdivision, to the chairs and ranking minority members of the legislative committees overseeing health and human services. By February 1, 2024, the first report must be submitted, and by January 1, 2025, the second report must be submitted.

In state legislatures and Congress this year, Media sources are monitoring more than 1,000 cannabis, psychedelic, and drug policy measures. To ensure they don’t miss any updates, Patreon backers who pledge at least $25 per month have access to our interactive maps, infographics, and hearing calendar. Find out more about our marijuana bill tracker and sign up as a Patreon patron to gain access.

Kurtis Hanna, a registered lobbyist for Minnesota NORML who is advancing this legislation pro bono as a citizen lobbyist, told Media sources that last week’s committee action to adopt the psychedelics measure to the omnibus brings us one step closer to the Minnesota executive branch being formally tasked with studying the therapeutic potential of these substances, which have been wrongfully stigmatized for far too long.

If the State legislature grants Minnesotans access to these drugs in a future session, further legal research will be necessary, he added, with an emphasis on lowering the chance of breaking federal law. Since medical cannabis has been legal in Minnesota since 2014, nothing substantive has ever been done in this regard.

The legislators of future legislative sessions will be much better prepared to decide whether to allow Minnesotans to legally access psychedelic medications if they finally take these substances seriously, Hanna said. This could pave the way for a revolution in the way mental health is handled in our state.


Mohit Kumar

About Author

Leave a comment

Your email address will not be published. Required fields are marked *

You may also like


‘All this silliness’ - UK cannabis chocolate bar case dropped

A couple who faced drug charges over cannabis-laced chocolate bars have had the case against them dropped. Prosecutors said they

Testing lab shut down over contaminated weed

A cannabis testing lab in Las Vegas has been shut down after it approved products with unacceptable levels of mould,